Invitae Corporation (NYSE:NVTA), a medical genetics company, said it is offering its Detect genetic testing programs free of charge for four conditions.

The In-vitro diagnostics Market size is set to exceed USD 92 billion by 2024; according to a new research report by Global Market Insights. Rising adoption rate of automated laboratory equipment and machines